Highlights from 2015: A Stellar Year

Last year marked a stellar year for Trendlines; our Trendlines Medical, Trendlines Agtech, and Trendlines Labs business units; and our portfolio companies. We are pleased to share highlights of some of the many achievements and accomplishments from 2015.

Going Public & Going Global with Our Investments

Sounding the gong for the opening of trading.

Sounding the gong for the opening of trading at the Singapore Stock Exchange.

Many hours, days, weeks and months were spent preparing for newest chapter: our successful IPO. We became a public company trading on the Catalist of the SGX (SGX:42T) on November 26, 2015. We are the first Israeli company to trade on the Catalist and the second Israeli company listed on the SGX.

Prior to the IPO, Trendlines entered into a memorandum of understanding with B. Braun Melsungen AG, one of the world’s leading health care suppliers. According to the agreement, bbraun Trendlines and B. Braun will cooperate to establish mutual deal flow, identify potential new investments, work together in the establishment of incubators, and collaborate on the development of new technologies, solutions, and products in medical fields. At the same time, B. Braun invested S$7.1 million in the Trendlines’ IPO.

In parallel to these immense efforts, our teams continued business as usual fulfilling our mission to create and develop companies to improve the human condition.

Growing Our Portfolio

Gordian Surgical trocar

Gordian Surgical’s trocar with built-in closure device

During 2015, we established five new portfolio companies. Three medical companies, ElastiMed, Tandem Technologies, and Zeev Implants, and two agritech companies, Enolog Technologies, and Neopterix Solutions. In 2015, our portfolio companies raised more than US$10 million in follow on capital. Among the companies that had successful raises were Catalyst Agtech, Leviticus Cardio, S.T.Stent, Sol Chip, ElastiMed, and Gordian Surgical. A number of companies reached significant milestones:

  • ET View signed a distribution agreement for its visualization and monitoring system in China and announced successful clinical trial results.
  • ApiFix received Israeli regulatory certification for its minimally invasive device to treat adolescent scoliosis, exceeded the 65-patient surgical mark, and expanded commercialization efforts in Europe.
  • Leviticus Cardio announced a successful animal trial and received ISO certification for its unique wireless energy system for patients with ventricular assist devices.
  • Sol Chip began integration of its everlasting solar battery in streetlamps in a smart city project in Israel.
  • BioFishency, EdenShield, and Advanced Mem-Tech all successfully launched sales.

Investigating Merger & Acquisition (M&A) Opportunities

At the end of 2015, three portfolio companies had contracts with investment banks to explore possible M&A opportunities. One of the companies, ET View, which is publicly traded on the Tel Aviv Stock Exchange, announced to the public on January 7, 2016, that it received expressions of interest from several potential acquirers and they had signed confidentiality agreements in order to examine the company’s information.

Organizing 5 Events in 5 Months

AgriVest 2015 networking

Networking at AgriVest 2015 against the spectacular backdrop of the Weizmann Institute of Science campus.

During the first half of 2015, Trendlines organized and participated in five different investment events.

  • We kicked off the year with our 5th Annual Company Showcase. The 350 attendees heard presentations by 13 of our agritech and medical technology and a keynote by OurCrowd founder, Jon Medved.
  • In March, six medical technology companies met investors in five United States cities on a Trendlines Medical Road Show, which received extensive press coverage in the local business press.
  • Trendlines Agtech’s 3rd Agrivest Conference was held in April 2015 at the Weizmann Institute of Science. The conference attracted more than 350 participants from all over the globe. Twelve agritech start-ups took part in the presentation competition. Two panels of global agritech experts and investors rounded out the discussions, and Pamela Marrone, CEO of Marrone Bio Innovations, provided insights into an agtech entrepreneur’s journey from idea to public company in her personal keynote address.
Biomed booth activity

Vensica CEO Avner Geva (light blue shirt) explains the company’s ultrasound-assisted drug-delivery catheter.

  • Trendlines Agtech exhibited at the 19th International Agritech conference held in Tel Aviv from April 28 to 30. We forged new connections with entrepreneurs, investors and industry leaders in the agritech space. Some of the Trendlines Agtech portfolio companies created a buzz in the start-up pavilion at the exhibition.
  • For the 10th consecutive year, Trendlines Medical exhibited at the Biomed Conference in Israel in May. The Trendlines Medical booth was a hub of activity for three days, attracting entrepreneurs, inventors, and investors from around the world, who met with Trendlines Medical managers and staff.

Strengthening Our Competitive Efforts

GreenSpense F&S Award LogoIn the third quarter of 2015, Trendlines Medical competed in and was awarded a tender by the Israel’s Office of the Chief Scientist of the Ministry of Economy to continue to operate as a technology incubator under government license for an additional eight years. In addition, a number of our portfolio companies were recognized in prestigious competitions:

  • GreenSpense received the Frost & Sullivan Sustainable Packaging New Product Innovation Award.
  • Enolog Technologies took second place in the GITR competition.
  • Endobetix was a finalist for Red Herring Europe’s Top 100 award.
  • BioFishency won second place at AgriVest 2015.
  • SolChip was named Most Innovative Israeli Start-Up at iNNOVEX 2015.

Agreeing to Collaborate

logo-rambamTrendlines Labs signed a collaboration agreement with Rambam Health Care Campus, the third such agreement with a major Israeli health organization. Its collaboration agreement with a global top-20 medical technology company bore fruit in 2015, with the first product (for the urology sector) developed by Labs being marketed by the company.

Looking Ahead to 2016

We look forward to an exciting 2016, filled with new opportunities and achievements. On January 27, 2016, we will hold our 6th Annual Company Showcase, which is ramping up to be the biggest yet, attracting participants from Israel, Singapore, Europe, China, and the United States. We will return to Biomed in May; in September, we will sponsor the 4th Annual AgriVest.

Trendlines continues to create and develop companies to improve the human condition through its strong relationships with our entrepreneurs, inventors, research institutions, and industry players.

Leave a Reply

  • Welcome to Trendlines

    We invest in, incubate, and support early-stage, high-promise medical and agricultural technology companies in Israel, a global leader in start-up ingenuity. Read More >

  • Categories

  • Subscribe to Our Newsletter

  • Stay in Touch

    icon-facebook Like us on Facebook

    icon-Twitter Follow us on Twitter

    icon-Linkedin Connect with us on Linkedin

    YouTube-color See us on YouTube

    flipboard  Read us on Flipboard

    google+_icon Join us on Google+